179 related articles for article (PubMed ID: 17703636)
1. Risk reduction with clopidogrel in the management of peripheral arterial disease.
Nayak KR; Cavendish JJ
Vasc Health Risk Manag; 2007; 3(3):289-97. PubMed ID: 17703636
[TBL] [Abstract][Full Text] [Related]
2. The role of platelets in peripheral arterial disease: therapeutic implications.
Matsagas MI; Geroulakos G; Mikhailidis DP
Ann Vasc Surg; 2002 Mar; 16(2):246-58. PubMed ID: 11972262
[TBL] [Abstract][Full Text] [Related]
3. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
Mohler ER
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
[No Abstract] [Full Text] [Related]
5. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
[TBL] [Abstract][Full Text] [Related]
6. [Myocardial infarct, stroke and vascular events reduced by a third].
Z Kardiol; 1997 Nov; 86(11 Suppl Myokardinf):1-3. PubMed ID: 9437253
[No Abstract] [Full Text] [Related]
7. Antiplatelet therapy in peripheral arterial disease.
Aronow WS
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):265-7. PubMed ID: 15379619
[TBL] [Abstract][Full Text] [Related]
8. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
[TBL] [Abstract][Full Text] [Related]
9. Emerging drugs in peripheral arterial disease.
Tulsyan N; Ouriel K; Kashyap VS
Expert Opin Emerg Drugs; 2006 Mar; 11(1):75-90. PubMed ID: 16503827
[TBL] [Abstract][Full Text] [Related]
10. Aspirin versus clopidogrel for synthetic graft patency after peripheral arterial bypass grafting.
Duran E; Canbaz S; Ege T; Acipayam M
Platelets; 2001 Dec; 12(8):503-4. PubMed ID: 11798400
[No Abstract] [Full Text] [Related]
11. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
Bhatt DL; Flather MD; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Fabry-Ribaudo L; Hu T; Topol EJ; Fox KA;
J Am Coll Cardiol; 2007 May; 49(19):1982-8. PubMed ID: 17498584
[TBL] [Abstract][Full Text] [Related]
12. Rationale for the use of platelet aggregation inhibitors in PAD patients.
Agnelli G
Vasc Med; 2001; 6(3 Suppl):13-5. PubMed ID: 11789961
[TBL] [Abstract][Full Text] [Related]
13. Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
Hiatt WR; Krantz MJ
Vasc Med; 2006 Feb; 11(1):55-60. PubMed ID: 16669416
[TBL] [Abstract][Full Text] [Related]
14. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
Cavendish JJ; Safani M
Curr Med Res Opin; 2004 Nov; 20(11):1851-5. PubMed ID: 15537486
[TBL] [Abstract][Full Text] [Related]
15. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
[No Abstract] [Full Text] [Related]
16. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Bhatt DL; Topol EJ;
Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
[TBL] [Abstract][Full Text] [Related]
18. Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy.
Hiatt WR
J Intern Med; 2002 Mar; 251(3):193-206. PubMed ID: 11886478
[TBL] [Abstract][Full Text] [Related]
19. Ticlopidine and clopidogrel.
Quinn MJ; Fitzgerald DJ
Circulation; 1999 Oct; 100(15):1667-72. PubMed ID: 10517740
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet therapy in the treatment of atherothrombotic disease: considering the evidence.
Aronow WS
Geriatrics; 2007 Apr; 62(4):12-24. PubMed ID: 17408314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
